CiRC Biosciences

Chicago, IL · Founded 2019 · Privately Held (backing)

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.

Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024

Who backs CiRC Biosciences?

5 investors
InvestorType
Valor Equity PartnersGrowth equity
HSC Next—
Harmony Biosciences Holdings—
Paragon Biosciences—
Portal Innovations—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CiRC Biosciences investors

5 investors are on record for CiRC Biosciences, including Valor Equity Partners, HSC Next, Harmony Biosciences Holdings and Paragon Biosciences. The debt round in Apr 2024 drew 19 investors.

Free account
More of CiRC Biosciences with a free account
  • ·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like CiRC Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View